Bayraktar S - Search Results

1

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.

Bayraktar S, Gutierrez-Barrera AM, Liu D, Tasbas T, Akar U, Litton JK, Lin E, Albarracin CT, Meric-Bernstam F, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK. Bayraktar S, et al. Breast Cancer Res Treat. 2011 Nov;130(1):145-53. doi: 10.1007/s10549-011-1711-z. Epub 2011 Aug 10. Breast Cancer Res Treat. 2011. PMID: 21830012 Free PMC article.

2

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.

Bayraktar S, Gutierrez-Barrera AM, Lin H, Elsayegh N, Tasbas T, Litton JK, Ibrahim NK, Morrow PK, Green M, Valero V, Booser DJ, Hortobagyi GN, Arun BK. Bayraktar S, et al. Clin Exp Metastasis. 2013 Jun;30(5):631-42. doi: 10.1007/s10585-013-9567-8. Epub 2013 Feb 1. Clin Exp Metastasis. 2013. PMID: 23370825 Free PMC article.

3

Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.

Bayraktar S, Zhou JZ, Bassett R, Gutierrez Barrera AM, Layman RM, Valero V, Arun B. Bayraktar S, et al. Breast J. 2020 Aug;26(8):1572-1582. doi: 10.1111/tbj.13922. Epub 2020 Jun 4. Breast J. 2020. PMID: 32497289

4

Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer Patients.

Bayraktar S, Avery T, Altundag K, Broglio K, Arun BK. Bayraktar S, et al. Breast J. 2013 Jul-Aug;19(4):431-4. doi: 10.1111/tbj.12141. Epub 2013 May 23. Breast J. 2013. PMID: 23701522 Free PMC article.

5

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.

Bayraktar S, Amendola L, Gutierrez-Barrera AM, Hashmi SS, Amos C, Gambello M, Ready KJ, Arun B. Bayraktar S, et al. Breast. 2014 Dec;23(6):770-4. doi: 10.1016/j.breast.2014.08.010. Epub 2014 Sep 16. Breast. 2014. PMID: 25231195

6

Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.

Bayraktar S, Jackson M, Gutierrez-Barrera AM, Liu D, Meric-Bernstam F, Brandt A, Woodson A, Litton J, Lu KH, Valero V, Arun BK. Bayraktar S, et al. Breast J. 2015 May-Jun;21(3):260-7. doi: 10.1111/tbj.12392. Epub 2015 Mar 19. Breast J. 2015. PMID: 25789811 Free PMC article.

7

Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.

Bayraktar S, Qiu H, Liu D, Shen Y, Gutierrez-Barrera AM, Arun BK, Sahin AA. Bayraktar S, et al. Biomark Cancer. 2015 Aug 18;7:39-49. doi: 10.4137/BIC.S29716. eCollection 2015. Biomark Cancer. 2015. PMID: 26327783 Free PMC article.

8

BRCA mutation genetic testing implications in the United States.

Bayraktar S, Arun B. Bayraktar S, et al. Breast. 2017 Feb;31:224-232. doi: 10.1016/j.breast.2016.11.021. Epub 2016 Dec 6. Breast. 2017. PMID: 27931006 Review.

9

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM. Bayraktar S, et al. Cancer. 2012 Mar 1;118(5):1202-11. doi: 10.1002/cncr.26439. Epub 2011 Jul 28. Cancer. 2012. PMID: 21800293 Free PMC article.

10

Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.

Arun B, Bayraktar S, Liu DD, Gutierrez Barrera AM, Atchley D, Pusztai L, Litton JK, Valero V, Meric-Bernstam F, Hortobagyi GN, Albarracin C. Arun B, et al. Among authors: bayraktar s. J Clin Oncol. 2011 Oct 1;29(28):3739-46. doi: 10.1200/JCO.2011.35.2682. Epub 2011 Sep 6. J Clin Oncol. 2011. PMID: 21900106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters